Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section with Delaware and District of Columbia and updated the page revision to v3.3.3. The prior revision v3.3.2 removed Delaware/DC Locations and the HHS Vulnerability Disclosure.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoval of the government funding and operating status notice from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check55 days agoChange DetectedThe updated page shows a revised layout and styling, but core study content (purpose, eligibility criteria, primary outcomes, enrollment, dates, and locations) appears unchanged. No significant data changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check84 days agoChange DetectedCore page now includes a government funding lapse notice and a new v3.2.0 release, replacing v3.1.0; this affects perceived reliability and versioning of the page.SummaryDifference5%

- Check91 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. This is a metadata revision with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.